Symbols / CERO Stock $0.01 +1.44% CERo Therapeutics Holdings, Inc.

Healthcare • Biotechnology • United States • OQB
CERO (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Christopher B. Ehrlich M.B.A.
Exch · Country OQB · United States
Market Cap 478.19K
Enterprise Value 7.44M
Income -95.96M
Sales —
FCF (ttm) -5.14M
Book/sh -0.46
Cash/sh 0.02
Employees 8
Insider 10d —
IPO Nov 30, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 0.00
Forward P/E -0.00
PEG —
P/S —
P/B -0.02
P/C —
EV/EBITDA -0.38
EV/Sales —
Quick Ratio 0.08
Current Ratio 0.14
Debt/Eq —
LT Debt/Eq —
EPS (ttm) 9.04
EPS next Y -3.26
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2025-11-19
Earnings (prior) 2025-11-19
ROA -241.15%
ROE —
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 45.11M
Shs Float 43.14M
Insider Own 4.13%
Instit Own 0.14%
Short Float 10.50%
Short Ratio 0.83
Short Interest 192.89K
52W High 26.99
vs 52W High -99.96%
52W Low 0.01
vs 52W Low 6.00%
Beta —
Impl. Vol. —
Rel Volume 1.26
Avg Volume 649.87K
Volume 818.28K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.01
Price $0.01
Change 1.44%
About

CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company's lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.01
Latest analyst target
3. DCF / Fair value
$-2.05
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.01
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-11-18 down D. Boral Capital Buy → Hold —
2025-10-30 main D. Boral Capital Buy → Buy $30
2025-10-22 main D. Boral Capital Buy → Buy $30
2025-10-13 main D. Boral Capital Buy → Buy $30
2025-09-23 main D. Boral Capital Buy → Buy $30
2025-09-09 main D. Boral Capital Buy → Buy $30
2025-09-05 main D. Boral Capital Buy → Buy $30
2025-08-04 main D. Boral Capital Buy → Buy $30
2025-06-24 main D. Boral Capital Buy → Buy $30
2025-06-23 up D. Boral Capital Hold → Buy $30
2025-05-30 down D. Boral Capital Buy → Hold —
2025-05-19 init Maxim Group — → Buy $3
2025-04-25 main D. Boral Capital Buy → Buy $11
2025-04-23 main D. Boral Capital Buy → Buy $11
2025-04-22 init D. Boral Capital — → Buy $11
News
RSS: Latest CERO news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-03-31 ATWOOD BRIAN G Director — 294,460 $0.00 $29
2024-12-13 YK BIOVENTURES OPPORTUNITIES GP I, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 5,957,250 $0.06 $400,456
2024-12-10 YK BIOVENTURES OPPORTUNITIES GP I, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 3,658,364 $0.09 $383,370
2024-10-10 YK BIOVENTURES OPPORTUNITIES GP I, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 3,250,000 $0.10 $325,000
2024-09-25 EHRLICH CHRISTOPHER B Chief Executive Officer — 5,312,983 — —
2024-09-25 LAPORTE KATHLEEN D Director — 965,997 — —
2024-09-25 ATWOOD BRIAN G Director — 19,358,578 — —
2024-09-25 SLOAN STUART M Beneficial Owner of more than 10% of a Class of Security — 532,486 $0.10 $55,538
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
19.33
+151.81%
7.68
-35.89%
11.97
+3.06%
11.62
Research And Development
10.38
+96.31%
5.29
-46.28%
9.85
+7.76%
9.14
Selling General And Administration
8.94
+274.81%
2.39
+12.27%
2.13
-14.27%
2.48
General And Administrative Expense
8.94
+274.81%
2.39
+12.27%
2.13
-14.27%
2.48
Salaries And Wages
0.86
—
—
—
Other Gand A
8.08
+238.63%
2.39
+12.27%
2.13
-14.27%
2.48
Total Expenses
19.33
+151.81%
7.68
-35.89%
11.97
+3.06%
11.62
Operating Income
-19.33
-151.81%
-7.68
+35.89%
-11.97
-3.06%
-11.62
Total Operating Income As Reported
-18.46
-140.56%
-7.68
+35.89%
-11.97
-3.06%
-11.62
EBITDA
-18.24
-178.15%
-6.56
+39.83%
-10.90
-0.16%
-10.88
Normalized EBITDA
-17.64
-156.81%
-6.87
+36.99%
-10.90
-0.16%
-10.88
Reconciled Depreciation
1.09
-2.79%
1.12
+4.14%
1.07
+45.87%
0.74
EBIT
-19.33
-151.81%
-7.68
+35.89%
-11.97
-3.06%
-11.62
Total Unusual Items
-0.61
-295.73%
0.31
—
—
Total Unusual Items Excluding Goodwill
-0.61
-295.73%
0.31
—
—
Special Income Charges
-0.61
-7533.93%
0.01
—
—
Other Special Charges
—
-0.01
—
—
Write Off
0.61
—
—
—
Net Income
-19.92
-173.27%
-7.29
+38.38%
-11.83
-11.28%
-10.63
Pretax Income
-19.92
-173.27%
-7.29
+38.38%
-11.83
-11.28%
-10.63
Net Non Operating Interest Income Expense
0.01
-91.60%
0.14
-2.66%
0.14
-85.60%
0.99
Net Interest Income
0.01
-91.60%
0.14
-2.66%
0.14
-85.60%
0.99
Interest Income Non Operating
0.01
-91.60%
0.14
-2.66%
0.14
-85.60%
0.99
Interest Income
0.01
-91.60%
0.14
-2.66%
0.14
-85.60%
0.99
Other Income Expense
-0.61
-344.88%
0.25
—
—
Other Non Operating Income Expenses
0.00
+100.39%
-0.06
—
—
Gain On Sale Of Security
—
0.30
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-19.92
-173.27%
-7.29
+38.38%
-11.83
-11.28%
-10.63
Net Income From Continuing Operation Net Minority Interest
-19.92
-173.27%
-7.29
+38.38%
-11.83
-11.28%
-10.63
Net Income From Continuing And Discontinued Operation
-19.92
-173.27%
-7.29
+38.38%
-11.83
-11.28%
-10.63
Net Income Continuous Operations
-19.92
-173.27%
-7.29
+38.38%
-11.83
-11.28%
-10.63
Normalized Income
-19.31
-154.18%
-7.60
+35.76%
-11.83
-11.28%
-10.63
Net Income Common Stockholders
-95.53
-1210.45%
-7.29
+38.38%
-11.83
-11.28%
-10.63
Otherunder Preferred Stock Dividend
0.08
0.00
—
—
Diluted EPS
-22.58
+98.41%
-1,416.55
+45.74%
-2,610.71
-11.28%
-2,345.98
Basic EPS
-22.58
+98.41%
-1,416.55
+45.74%
-2,610.71
-11.28%
-2,345.98
Basic Average Shares
4.23
+70823.02%
0.01
+31.63%
0.00
+0.00%
0.00
Diluted Average Shares
4.23
+70823.02%
0.01
+31.63%
0.00
+0.00%
0.00
Diluted NI Availto Com Stockholders
-95.53
-1210.45%
-7.29
+38.38%
-11.83
-11.28%
-10.63
Preferred Stock Dividends
75.52
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
3.64
-41.34%
6.21
+21.08%
5.13
-54.83%
11.35
Current Assets
2.73
-26.38%
3.71
+88.53%
1.97
-72.16%
7.08
Cash Cash Equivalents And Short Term Investments
1.66
-50.03%
3.33
+107.78%
1.60
-76.52%
6.82
Cash And Cash Equivalents
1.66
-50.03%
3.33
+107.78%
1.60
-76.52%
6.82
Cash Financial
1.66
-50.03%
3.33
+107.78%
1.60
-76.52%
6.82
Current Deferred Assets
0.00
-100.00%
0.11
0.00
—
Other Current Assets
1.07
+290.14%
0.27
-25.50%
0.37
+43.80%
0.26
Total Non Current Assets
0.91
-63.62%
2.49
-21.02%
3.16
-26.14%
4.27
Net PPE
0.91
-54.50%
1.99
-36.86%
3.16
-26.14%
4.27
Gross PPE
3.22
-20.00%
4.02
-15.29%
4.74
-12.16%
5.40
Accumulated Depreciation
-2.31
-13.94%
-2.03
-27.60%
-1.59
-40.87%
-1.13
Properties
—
—
—
0.00
Buildings And Improvements
—
—
—
2.85
Machinery Furniture Equipment
0.05
+0.00%
0.05
+0.00%
0.05
+0.00%
0.05
Other Properties
3.17
-20.23%
3.97
-15.44%
4.70
-12.26%
5.35
Non Current Deferred Assets
0.00
-100.00%
0.50
0.00
—
Total Liabilities Net Minority Interest
9.09
+12.17%
8.10
-82.83%
47.18
+2.09%
46.22
Current Liabilities
9.09
+22.77%
7.40
+111.07%
3.51
+201.31%
1.16
Payables And Accrued Expenses
8.20
+30.95%
6.26
+258.29%
1.75
+270.41%
0.47
Payables
8.08
+73.04%
4.67
+179.42%
1.67
+327.35%
0.39
Accounts Payable
7.58
+68.19%
4.51
+169.62%
1.67
+327.35%
0.39
Other Payable
0.34
—
—
—
Dividends Payable
0.09
+0.00%
0.09
0.00
—
Current Accrued Expenses
0.12
-92.68%
1.59
+1994.43%
0.08
-5.83%
0.08
Pensionand Other Post Retirement Benefit Plans Current
0.17
-30.87%
0.24
+255.62%
0.07
+247.69%
0.02
Total Tax Payable
0.08
+0.00%
0.08
0.00
—
Current Debt And Capital Lease Obligation
0.70
-20.23%
0.88
-35.97%
1.37
+103.57%
0.67
Current Debt
—
—
0.60
—
Current Capital Lease Obligation
0.70
-20.23%
0.88
+13.95%
0.77
+14.38%
0.67
Other Current Liabilities
0.02
+0.00%
0.02
-93.79%
0.32
—
Total Non Current Liabilities Net Minority Interest
0.00
-100.00%
0.70
-98.40%
43.68
-3.06%
45.06
Long Term Debt And Capital Lease Obligation
0.00
-100.00%
0.70
-55.63%
1.58
-32.80%
2.34
Long Term Capital Lease Obligation
0.00
-100.00%
0.70
-55.63%
1.58
-32.80%
2.34
Preferred Securities Outside Stock Equity
—
0.00
-100.00%
42.10
+0.00%
42.10
Stockholders Equity
-5.45
-187.48%
-1.89
+95.50%
-42.06
-20.61%
-34.87
Common Stock Equity
-12.71
-150.64%
-5.07
+87.94%
-42.06
-20.61%
-34.87
Capital Stock
7.27
+128.73%
3.18
+317645700.00%
0.00
-99.89%
0.00
Common Stock
0.00
+17483.33%
0.00
+1100.00%
0.00
-99.89%
0.00
Preferred Stock
7.26
+128.67%
3.18
0.00
—
Share Issued
21.10
+15198.44%
0.14
+2212.88%
0.01
+15.90%
0.01
Ordinary Shares Number
21.10
+15198.44%
0.14
+2212.88%
0.01
+15.90%
0.01
Additional Paid In Capital
78.13
+16.36%
67.14
+6405.25%
1.03
+11.15%
0.93
Retained Earnings
-90.84
-28.09%
-70.92
-64.58%
-43.09
-20.36%
-35.80
Total Equity Gross Minority Interest
-5.45
-187.48%
-1.89
+95.50%
-42.06
-20.61%
-34.87
Total Capitalization
-5.45
-187.48%
-1.89
+95.50%
-42.06
-20.61%
-34.87
Working Capital
-6.35
-72.25%
-3.69
-139.95%
-1.54
-126.00%
5.91
Invested Capital
-12.71
-150.64%
-5.07
+87.77%
-41.46
-18.89%
-34.87
Total Debt
0.70
-55.63%
1.58
-46.49%
2.94
-2.41%
3.02
Capital Lease Obligations
0.70
-55.63%
1.58
-32.80%
2.34
-22.29%
3.02
Net Tangible Assets
-5.45
-187.48%
-1.89
+95.50%
-42.06
-20.61%
-34.87
Tangible Book Value
-12.71
-150.64%
-5.07
+87.94%
-42.06
-20.61%
-34.87
Current Notes Payable
—
0.00
-100.00%
0.60
—
Derivative Product Liabilities
—
—
—
0.61
Interest Payable
—
0.00
-100.00%
0.03
—
Other Equity Interest
—
-1.30
—
—
Preferred Stock Equity
7.26
+128.67%
3.18
—
—
Line Item Trend 2025-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-16.08
-177.73%
-5.79
+50.55%
-11.71
-16.00%
-10.09
Cash Flow From Continuing Operating Activities
-16.08
-177.73%
-5.79
+50.55%
-11.71
-16.00%
-10.09
Net Income From Continuing Operations
-19.92
-173.27%
-7.29
+38.38%
-11.83
-11.28%
-10.63
Depreciation Amortization Depletion
1.09
-2.79%
1.12
+4.14%
1.07
+45.87%
0.74
Depreciation
1.09
-2.79%
1.12
+4.14%
1.07
+45.87%
0.74
Depreciation And Amortization
1.09
-2.79%
1.12
+4.14%
1.07
+45.87%
0.74
Other Non Cash Items
—
0.04
—
—
Stock Based Compensation
1.96
+1922.38%
0.10
-74.57%
0.38
+32.44%
0.29
Asset Impairment Charge
0.61
—
—
—
Operating Gains Losses
-0.00
+99.91%
-0.29
-684.67%
-0.04
+96.23%
-0.98
Gain Loss On Investment Securities
—
-0.29
-684.67%
-0.04
+96.23%
-0.98
Net Foreign Currency Exchange Gain Loss
-0.00
—
—
—
Change In Working Capital
0.19
-64.97%
0.54
+141.64%
-1.30
-363.45%
0.49
Change In Prepaid Assets
-0.80
-609.71%
-0.11
-326.51%
0.05
-49.26%
0.10
Change In Payables And Accrued Expense
1.86
+40.61%
1.32
+273.99%
-0.76
-210.47%
0.69
Change In Accrued Expense
-0.41
-1016.70%
0.04
+106.39%
-0.69
-245.19%
0.48
Change In Payable
2.27
+77.13%
1.28
+1963.07%
-0.07
-132.40%
0.21
Change In Account Payable
1.93
+50.72%
1.28
+1963.07%
-0.07
-132.40%
0.21
Change In Other Current Liabilities
-0.88
-30.34%
-0.67
-14.89%
-0.59
-98.63%
-0.29
Investing Cash Flow
0.50
—
-0.69
-13.33%
-0.61
Cash Flow From Continuing Investing Activities
0.50
—
-0.69
-13.33%
-0.61
Net PPE Purchase And Sale
—
—
-0.69
-13.33%
-0.61
Purchase Of PPE
—
—
-0.69
-13.33%
-0.61
Capital Expenditure
—
—
-0.69
-13.33%
-0.61
Net Investment Purchase And Sale
0.50
—
—
—
Sale Of Investment
0.50
—
—
—
Financing Cash Flow
13.92
+2334.16%
0.57
+10063.16%
0.01
-90.66%
0.06
Cash Flow From Continuing Financing Activities
13.92
+2334.16%
0.57
+10063.16%
0.01
-90.66%
0.06
Net Issuance Payments Of Debt
0.00
-100.00%
0.61
—
—
Issuance Of Debt
0.00
-100.00%
0.61
—
—
Repayment Of Debt
0.00
—
—
—
Long Term Debt Issuance
—
0.61
—
—
Long Term Debt Payments
0.00
—
—
—
Net Long Term Debt Issuance
0.00
-100.00%
0.61
—
—
Short Term Debt Issuance
0.00
0.00
—
—
Short Term Debt Payments
0.00
—
—
—
Net Short Term Debt Issuance
0.00
0.00
—
—
Net Common Stock Issuance
0.59
—
—
—
Repurchase Of Capital Stock
-0.40
—
—
—
Proceeds From Stock Option Exercised
9.34
+161899.22%
0.01
+2.51%
0.01
-90.66%
0.06
Net Other Financing Charges
-0.11
-168.12%
-0.04
—
—
Changes In Cash
-1.66
+68.10%
-5.22
+57.91%
-12.40
-16.45%
-10.65
Beginning Cash Position
3.33
-51.21%
6.82
-64.51%
19.22
-35.65%
29.86
End Cash Position
1.66
+3.82%
1.60
-76.52%
6.82
-64.51%
19.22
Free Cash Flow
-16.08
-177.73%
-5.79
+53.32%
-12.40
-15.85%
-10.71
Common Stock Issuance
0.59
—
—
—
Issuance Of Capital Stock
5.08
0.00
—
—
Net Preferred Stock Issuance
4.09
0.00
—
—
Preferred Stock Issuance
4.49
0.00
—
—
Preferred Stock Payments
-0.40
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category